Photo by dylu from unsplash
To compare the treatment efficacy and safety of tyrosine kinase inhibitors (TKIs) and anti‐programmed cell death 1 (PD‐1) immunotherapy combined with transarterial chemoembolization (TACE) or hepatic arterial infusion chemotherapy (HAIC)… Click to show full abstract
To compare the treatment efficacy and safety of tyrosine kinase inhibitors (TKIs) and anti‐programmed cell death 1 (PD‐1) immunotherapy combined with transarterial chemoembolization (TACE) or hepatic arterial infusion chemotherapy (HAIC) for patients with unresectable intrahepatic cholangiocarcinoma (ICC).
Keywords:
kinase inhibitors;
arterial infusion;
unresectable intrahepatic;
infusion chemotherapy;
tyrosine kinase;
hepatic arterial
Journal Title: Journal of Digestive Diseases
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Digestive Diseases
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!